The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
Context: The deletion of exon 3 in the GH receptor (GHR) has been associated with a different biochemical picture and response to therapy in acromegaly. Objective: The aim of the study was to determine whether or not the GHR genotype influences the efficacy of pegvisomant treatment. Design and Setti...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2010-01, Vol.95 (1), p.222-229 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!